Description
Retatrutide
Chemical Classification: GIP / GLP-1 / Glucagon Receptor Triple Agonist
Research Overview
Retatrutide is a synthetic 39-amino acid peptide that represents the next generation of metabolic research ligands. In biochemical studies, it is classified as a “Triple Agonist” due to its unique ability to bind and activate three distinct nutrient-stimulated hormone receptors: the Glucose-dependent Insulinotropic Polypeptide (GIP) receptor, the Glucagon-Like Peptide-1 (GLP-1) receptor, and the Glucagon (GCG) receptor. It is a primary subject in studies exploring the synergistic tri-pathway modulation of energy balance and nutrient metabolism.
Common Research Applications
This triple-hormone mimetic is frequently utilized in laboratory models to investigate the following experimental objectives:
- Triple-Pathway Synergy: Research focusing on the combined activation of GIP, GLP-1, and GCG receptors to observe the cumulative impact on insulin secretion and glucagon suppression.
- Thermogenesis and Energy Expenditure: Investigations into the specific role of the glucagon receptor activation in modulating metabolic rate and brown adipose tissue (BAT) thermogenesis.
- Hepatocyte Lipid Metabolism: Studies regarding the peptide’s influence on hepatic lipid accumulation and its potential role in modulating fatty acid oxidation within liver cell models.
- Hypothalamic Satiety Signaling: Research exploring the central nervous system’s response to triple-receptor stimulation, specifically focusing on the regulation of appetite and energy intake.
- Glycemic Homeostasis: Comparative analysis of retatrutide’s potency against dual-agonists (like Tirzepatide) or mono-agonists in maintaining blood glucose stability in non-human subjects.
Laboratory Handling & Storage
- Appearance: Lyophilized white powder.
- Solubility: Highly soluble in water, bacteriostatic water, or sterile saline.
- Stability: Stable at room temperature for transit. For long-term preservation, the lyophilized powder must be stored at -20°C.